Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-26
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 20-F · filed 2026-03-26 | |||
| 2025-06-30 | 0.00% 6-K · filed 2025-08-28 | |||
| 2024-12-31 | 0.00% 20-F · filed 2026-03-26 | |||
| 2024-05-07 | 0.00% 6-K · filed 2024-08-29 | |||
| 2023-12-31 | 0.00% 20-F · filed 2026-03-26 | |||
| 2022-12-31 | 0.00% 20-F · filed 2025-04-14 | |||
| 2021-12-31 | 0.00% 20-F · filed 2024-03-28 | |||
| 2021-04-13 | 0.00% 6-K · filed 2021-08-26 | |||
| 2020-12-31 | 0.00% 20-F · filed 2022-03-24 | |||
| 2020-05-27 | 0.00% 6-K · filed 2020-08-27 | |||
| 2019-12-31 | 0.00% 20-F · filed 2021-03-25 |